Galectin-3, new potential therapeutic target for cardiac remodelling

Eur J Heart Fail. 2013 Jun;15(6):709. doi: 10.1093/eurjhf/hft055. Epub 2013 Mar 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Female
  • Galectin 3 / blood*
  • Heart Failure / blood*
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Tetrazoles / therapeutic use*
  • Valine / analogs & derivatives*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Galectin 3
  • Tetrazoles
  • Valine